Chiron Corporation [clinicaltrials_resource:5bda8775a7a36fdd66fbca12c61324d2]
affiliation [clinicaltrials_vocabulary:affiliation]
Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals [clinicaltrials:NCT00001997]A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients [clinicaltrials:NCT00002107]A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults [clinicaltrials:NCT00002204]A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis [clinicaltrials:NCT00002321]Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy [clinicaltrials:NCT00002449]Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma. [clinicaltrials:NCT00045864]Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments [clinicaltrials:NCT00045877]Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00051688]Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer [clinicaltrials:NCT00054873]Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL) [clinicaltrials:NCT00100737]Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine [clinicaltrials:NCT00262015]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma. [clinicaltrials:NCT00045864]Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments [clinicaltrials:NCT00045877]Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00051688]Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer [clinicaltrials:NCT00054873]Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL) [clinicaltrials:NCT00100737]Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine [clinicaltrials:NCT00262015]
source [clinicaltrials_vocabulary:source]
Chiron Corporation [clinicaltrials_resource:5bda8775a7a36fdd66fbca12c61324d2]
Bio2RDF identifier
5bda8775a7a36fdd66fbca12c61324d2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5bda8775a7a36fdd66fbca12c61324d2
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:5bda8775a7a36fdd66fbca12c61324d2
title
Chiron Corporation
@en
type
label
Chiron Corporation [clinicaltrials_resource:5bda8775a7a36fdd66fbca12c61324d2]
@en